The Palico Private Equity Fund Marketplace
OrbiMed Israel is a private equity general partner firm located in Israel.
Israel-based Nutrinia, an insulin developer for infants, has raised $30m in Series D funding led by TPG Biotech.
Israel-based medical device company Keystone Heart, backed by OrbiMed, has appointed Chris Richardson as president and CEO.
Nucleix, an Israeli company that develops innovative non-invasive molecular cancer diagnostic tests, raised $3m in funding.
Read more news concerning OrbiMed Israel
A sampling of OrbiMed Israel portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?